脑室入路装置导引器:一个长期难题的新解决方案
作者设计了一种用于脑室穿刺的低轮廓装置(DIVE导引器),并在单中心前瞻性纳入50例接受脑室外引流或分流管置入的患者,评估其安全性、有效性和准确性。结果显示全部患者均成功置管,平均穿刺1.06次,术后CT证实92%(46/50)达到Kakarla 1级,无临床显著穿刺道出血或操作相关感染。
要点
- 50例患者中100%(50/50)成功完成脑室置管,平均穿刺1.06次。
- 术后CT显示92%(46/50)为同侧额角或第三脑室置管(Kakarla 1级),8%(4/50)为对侧侧脑室(Kakarla 2级)。
- 无临床显著穿刺道出血或操作相关感染。
核心结论
- DIVE辅助脑室入路在单中心前瞻性研究中显示100%脑室置管成功,92%达到Kakarla 1级,平均穿刺1.06次,无临床并发症。
研究设计与样本
- 由第一作者和资深作者设计并制作新型脑室入路装置DIVE导引器。
- 在单个学术中心前瞻性纳入50例接受脑室外引流或分流管置入的患者,行DIVE辅助导管置入。
- 主要结局为术后CT上的导管尖端位置,次要结局包括导管穿刺次数、临床显著出血和操作相关感染。
主要发现
- 50例患者中,适应证包括蛛网膜下腔出血、脑室内出血、创伤性脑损伤、脑积水、假瘤和术后创口引流。
- 76%(38/50)患者为右侧置管,24%(12/50)为左侧置管。
- 全部100%(50/50)患者成功置管,平均穿刺1.06次。
- 术后头颅CT证实92%(46/50)患者为同侧额角或第三脑室置管(Kakarla 1级),8%(4/50)为对侧侧脑室置管(Kakarla 2级)。
- 无临床显著穿刺道出血或操作相关感染。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors designed a low-profile device for reliable ventricular access and prospectively studied its safety, efficacy, and accuracy at a large academic center. METHODS: A novel device for ventricular entry, the Device for Intraventricular Entry (DIVE) guide, was designed and created by the first and senior authors. Fifty patients undergoing external ventricular drainage (EVD) or shunt placement were prospectively enrolled for DIVE-assisted catheter placement at a single academic center. The primary outcome was the catheter tip location on postprocedural CT. Secondary outcomes included number of catheter passes, clinically significant hemorrhages, and procedure-related infections. RESULTS: Fifty patients were enrolled. Indications included subarachnoid hemorrhage, intraventricular hemorrhage, traumatic brain injury, hydrocephalus, pseudotumor, and postsurgical wound drainage. In total, 76% (38/50) of patients underwent right-sided placement and 24% (12/50) underwent left-sided placement. All 100% (50/50) of patients had successful cannulation with an average of 1.06 passes. Postprocedural head CT confirmed ipsilateral frontal horn or third ventricle placement (Kakarla grade 1) in 92% (46/50) of patients and placement in the contralateral lateral ventricle in 8% (4/50) (Kakarla grade 2). There were no clinically significant track hemorrhages or procedural infections. CONCLUSIONS: This single-center prospective study investigated the safety and efficacy of DIVE-assisted ventricular access. In total, 100% of procedures had successful ventricular cannulation, with 92% achieving Kakarla grade 1, with an average of 1.06 passes without any clinical complications.
引用
- Spadola M, Muhammad N, Ajmera S, et al. The Device for Intraventricular Entry guide: a novel solution to a perpetual problem. J Neurosurg. 2023. PMID: 37976517. doi:10.3171/2023.8.JNS23693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。